Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from MHRA

‘These patients do not have time’: families in UK demand access to new drug that slows brain tumours

Vorasidenib worked in trials but is not yet available on the NHS

The Guardian - UK

‘I didn’t want to be here anymore’: The agony of women suffering with topical steroid withdrawal

The condition is caused after the repeated use of steroid creams and tablets commonly prescribed by the NHS, Holly Evans writes

The Independent UK

Patients in England will be first to access seven-minute cancer treatment jab

NHS is first health system to offer injection to hundreds of patients which will cut treatment times by up to three quarters

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Public bodies named and shamed over Freedom of Information request failings

The Information Commissioner’s Office urged organisations to ensure their performance and processes complied with the law.

The Independent UK

Why life-threatening allergic reactions are on the rise

Hospital admissions for life-threatening allergic reactions have increased from 12,361 in 2002-03 to 25,721 in the past year, latest NHS figures show.

The Week

Men sentenced for selling unauthorised Covid-19 tests during pandemic

Ron Huss-Smickler, 41 from Birmingham, and Steven Lawrence Beckford, 39 from Edgbaston, bought the non-certified coronavirus tests from Alibaba.

The Independent UK

Hospital admissions for life-threatening allergies more than double in England

Number of people taken to hospital increased to 25,721 in 2022-23, from 12,361 two decades before

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Hospital admissions for life-threatening allergic reactions ‘more than double’

Data obtained by drugs regulator the MHRA shows there were 25,721 admissions to England’s hospitals for allergies and anaphylaxis in 2022/23.

The Independent UK

Weight-loss drugs under review in UK after reports of suicidal thoughts

Ozempic and Saxenda among drugs being reviewed after five reports of suspected adverse reactions in patients

The Guardian - UK

Sciensus’s licence partly suspended after death of cancer patient

Regulator acts after firm paid millions by NHS for healthcare gave patients wrong chemotherapy dose

The Guardian - UK

Codeine cough syrup: Why is it being banned in UK pharmacies?

Abusing the medical mixture has prompted a ban on UK sales

Evening Standard

Cough syrups could be made prescription-only over addiction fears

UK medicines safety regulator says codeine linctus could have serious health condequences

The Independent UK

RSV vaccine for older adults approved by UK medicines regulator

Arexvy could help NHS deal with virus that causes about 8,000 deaths among older people in UK each year

The Guardian - UK

Investigation into risk of suicidal and self-harm thoughts among users of Wegovy, Saxenda and other weight loss jabs

It will also look at one used to for type 2 diabetes

Wales Online

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Drug regulator investigating suicidal thoughts among some weight-loss jab users

The European Medicines Agency is looking at Wegovy (semaglutide), Saxenda (liraglutide) and other similar drugs used to control appetite.

The Independent UK

Three cases of suicidal and self-harm thoughts identified in Iceland, regulator says

Daily Mirror

Cancer patient dies and 4 hospitalised after being given 'unlicensed' chemotherapy drug

The patient, who has not been named, was one of four people given an unlicensed version of prostate cancer medicine cabazitaxel, and authorities are now investigating

The Guardian - UK

Patient dies and three hospitalised in Sciensus chemotherapy incident

Exclusive: Regulators investigate after patients received unlicensed treatment from firm paid millions by NHS

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

My topical steroid withdrawal: ‘Water felt like acid, my body was ablaze and I shed skin like a snake’

I was prescribed steroid cream for my eczema – but when I stopped using it I ended up in A&E. Much more research is needed into this debilitating condition

The Guardian - UK

GPs could be offered bonuses to increase patient numbers in clinical trials

Package of measures for UK life sciences sector also includes overhauling regulatory process for new medicines

Daily Mirror

Allergy sufferers warned over adrenaline pens recall over fears they don’t work

Patients, or carers of patients, who carry Emerade 300 or 500 microgram adrenaline auto-injector pens should contact their GP, the government have announced after a precautionary recall

The Independent UK

Emerade adrenaline pens recalled ‘after potential faults detected’

The medicines regulator has urged patients to return Emerade 300 and 500 microgram adrenaline pens to their local pharmacies.

The National (Scotland)

Laurence Fox slammed by academic LIVE on GB News over vaccine claims

AN academic told GB News host Laurence Fox “I sometimes wonder why you exist” after the broadcaster claimed “conspiracy factualists” had…

Nottingham Post

‘Healthy’ doctor died after severe reaction to AstraZeneca Covid jab

He died 10 days after the injection

The Guardian - UK

Novartis scraps cholesterol drug trial in blow to UK life sciences ambitions

Swiss firm’s withdrawal from Leqvio trial with NHS dents government plans to attract post-Brexit research and investment

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Environment Agency

Liverpool City Council

European Medicines Agency

76 stories

Roche

74 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Freedom of Information Act

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.